The cerebrovascular response to decreases in hematocrit and viscosity depends on accompanying changes in arterial O 2 content. This study examines whether: 1) the arteriolar dilation seen after exchange transfusion with a 5% albumin solution can be reduced by the K ATP channel antagonist, glibenclamide (known to inhibit hypoxic dilation), and 2) the arteriolar constriction seen after exchange transfusion with a cell-free hemoglobin polymer to improve O 2 carrying capacity can be blocked by inhibitors of the synthesis or vasoconstrictor actions of 20-HETE. In anesthetized rats, decreasing hematocrit by one-third with albumin exchange transfusion dilated pial arterioles (14 ± 2%; SD), whereas superfusion of the surface of the brain with 10 µM glibenclamide blocked this response (-10 ± 7%). Exchange transfusion with polymeric hemoglobin decreased the diameter of pial arterioles by 20 ± 3% without altering arterial pressure.
JAP-00890-2005.R1 6 does not interfere with the inhibitory effect of an ω-hydroxylase inhibitor on the response, and 3) that the pial arteriolar dilation seen after exchange transfusion with an albumin-containing solution is reduced by local application of an inhibitor of ATPsensitive potassium (K ATP ) channels. The rationale for the latter hypothesis is based on the assumption that the dilation is the result of a hypoxic stimulus accompanying the decrease in O 2 carrying capacity (34, 36) , and on the evidence that K ATP channels contribute to pial arteriolar dilation associated with hypoxic hypoxia (29, 31).
METHODS
All procedures were approved by the Johns Hopkins University Animal Care and Use Committee. Male Wistar rats weighing 250-300 g were anesthetized with halothane JAP-00890-2005.R1 7 arteriole segment and on two different arterioles in each window. For each intervention, the percent change in arteriolar diameter was calculated at each site. An average percent change was then obtained for each rat, and this average value was used for statistical analysis, with the sample size equal to the number of rats.
Exchange transfusion was performed over a 15-minute period by administration of a 5% solution of human albumin or a 6% solution of a hemoglobin polymer.
Approximately 7 ml of blood was removed from the rat via the arterial catheter while simultaneously replacing with an intravenous infusion of either solution to reduce hematocrit by ~30%. The process for polymerization, purification, and removal of endotoxin from the solution of the bovine hemoglobin polymer in lactated Ringer's has been previously described (19, 25) . The polymers are characterized by covalent amide bonds linking the tetramers (zero-link bovine hemoglobin polymer). Low molecular weight species (< 300 kDa) were removed from the hemoglobin solution by diafiltration in which the retentate contains polymers with an estimated average molecular weight of 20 MDa. The polymeric hemoglobin has a high O 2 -affinity (P 50 ~ 4 mmHg at 50% O 2 saturation) with poor cooperativity (Hill coefficient of ~1).
To assess the role of 20-HETE in the arteriolar response to hemoglobin transfusion, the window was superfused with either 1) the putative 20-HETE antagonist WIT002 (20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (also known as 20-HEDE; 10 µM) (5, 37); 2) a selective inhibitor of the synthesis of 20-HETE, DDMS (N-methylsulfonyl-12,12-dibromododec-11-enamide; 50 µM) (5, 35); or 3) a structurally dissimilar inhibitor JAP-00890-2005.R1 8 been shown to be efficacious in the cerebral circulation of rats (5, 15). To test the role of NO in the vascular response to hemoglobin transfusion, the window was superfused with the NOS inhibitor N ω -nitro-L-arginine (L-NNA; 300 µM). To test the role of K ATP channels in the arteriolar response to albumin exchange transfusion, the window was superfused with 10 µM glibenclamide. Vehicle or a single drug diluted in artificial CSF was superfused through the cranial window at a rate of 0.2 ml/min for 20 minutes prior to the start of the exchange transfusion. Fluid pressure in the window was maintained at 5 mmHg by adjusting the height of the outflow catheter.
Six groups of rats were studied with hemoglobin exchange transfusion: 1) vehicle (0.25% ethanol; n = 6); 2) WIT002 (n = 6); 3) DDMS (n = 7); 4) HET0016 (n = 6); 5) L-NNA (n = 6); and 6) L-NNA + DDMS (n = 6). The combined L-NNA + DDMS group was studied to determine if the effect of DDMS on the vascular response required NOS activity. Two groups of rats were studied with albumin transfusion:1) vehicle (0.1% DMSO; n = 6); and 2) glibenclamide (n = 6).
The percent change in arteriolar diameter was measured immediately after completing the exchange transfusion and 30 and 60 minutes later. To test if the pial arterioles were still capable of constriction after the various drug treatments, the vascular response to superfusion of the pial window with the thromboxane analog U46619 (0.1 µM) was determined at the end of each experiment.
Statistics: Values are presented as means ± SD. The significance of differences in the percent change in arteriolar diameter at various time points in drug and vehicle treated groups was evaluated by analysis of variance and the Newman-Keuls multiple range test.
JAP-00890-2005.R1 9 A P value < 0.05 was considered to be significant. Arterial blood measurements made after transfusion were compared to the pre-transfusion values by paired t-test.
RESULTS
Exchange transfusion with the zero-link bovine hemoglobin polymer decreased hematocrit from 36-40% to 27-29%. This was accompanied by only a small decrease in blood hemoglobin concentration (Table 1 ). In contrast, exchange transfusion with the albumin solution produced a large decrease in blood hemoglobin concentration, with a similar reduction in hematocrit. Arterial PCO 2 was controlled in the range of 36-40 mmHg and was not significantly altered by the transfusion. Arterial PO 2 was maintained at approximately 130 mmHg in all rats, and arterial pH was maintained in the range of 7.40-7.45 (data not shown). Mean arterial blood pressure was not significantly changed after transfusion of hemoglobin polymer, although a small decrease occurred after transfusion of the albumin solution (Table 1) . Rectal temperature and fluid temperature in the cranial window were both in the range of 36.8°-37.5°C before and after transfusion in all groups.
Immediately after completing the exchange transfusion with the polymeric hemoglobin solution, the diameter of the pial arterioles fell by 20%. This constrictor response was attenuated by 75% by superfusing the surface of the brain with 10 µM WIT002 and was completely blocked in the groups superfused with 50 µM DDMS and 1 µM HET0016 (Fig. 1 ).
Previous studies have indicated that the formation of 20-HETE is directly dependent on tissue PO 2 levels in the physiologic range from 20-100 mm Hg and is JAP-00890-2005.R1 11 between 0 minute and 60 minutes after completing the hemoglobin transfusion was greater in the vehicle group than in any of the drug-treated groups.
Exchange transfusion with the albumin solution produced a 14% dilation of pial arteries relative to the baseline diameter after vehicle superfusion. The dilation did not vary over the 60-minute observation period (Fig. 3) , and the response was significantly different from that seen with hemoglobin transfusion over the entire 60 minutes.
Superfusion of 10 µM glibenclamide did not affect baseline arteriolar diameter compared to vehicle, but completely blocked the dilator response to albumin transfusion at all time points (Fig. 3) .
Superfusion of the surface of the brain with 0.1 µM U46619 one hour after transfusion reduced the diameter of pial arterioles in all groups (Fig. 4) In addition to its O 2 dependency, the formation of 20-HETE in isolated cerebral arteries is augmented by increases in transmural pressure (5). Thus, one needs to consider whether an increase in transmural pressure might also provide the initial stimulus for pial arteriolar constriction by a 20-HETE -dependent mechanism. At constant aortic pressure, pial arteriolar intravascular pressure would increase if the effect decreased blood viscosity resulted in a disproportionately greater reduction in the pressure drop across extraparenchymal resistance vessels compared to that across the intraparenchymal resistance vessels. However, because the major effect of reducing hematocrit is on blood viscosity at low shear rates present in the microcirculation, one would not anticipate a disproportionate effect on the macrocirculation vascular resistance. Indeed, servo-null measurements did not demonstrate a significant change in pial arteriolar intravascular pressure with reduced hematocrit in rats (12). Thus, an increase in pial arteriolar transmural pressure is unlikely to be the major contributor to the observed 20% constriction after hemoglobin exchange transfusion.
Another consideration is that 20-HETE production is strongly inhibited by NO. Values are means ± SD. There were no significant differences between the treatment groups and the respective vehicle groups. 
